Filing Details
- Accession Number:
- 0001013762-15-000731
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-16 07:07:17
- Reporting Period:
- 2015-07-16
- Filing Date:
- 2015-07-16
- Accepted Time:
- 2015-07-16 07:07:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1498382 | Delmar Pharmaceuticals Inc. | DMPI | Pharmaceutical Preparations (2834) | 990360497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1332948 | Scott Praill | Suite 720-999 West Broadway Vancouver A1 V5Z 1K5 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-16 | 50,000 | $0.60 | 60,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2015-07-16 | 50,000 | $0.00 | 50,000 | $0.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,000 | 2015-07-16 | 2020-07-16 | No | 4 | P | Direct |